KeyBank National Association’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

KeyBank National Association’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-713	Closed	-$6.48K	–	1107
2023 Q1	$6.48K	Hold	713	–	–	﹤0.01%	1051
2022 Q4	$8.37K	Hold	713	–	–	﹤0.01%	1052
2022 Q3	$15K	Hold	713	–	–	﹤0.01%	1039
2022 Q2	$17K	Buy	+713	New	+$24.3K	﹤0.01%	1059

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KeyBank National Association's VBIV Position: Q2 2023 in Review

KeyBank National Association sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 713 shares — an estimated $6.48K sold.

KeyBank National Association first reported a position in VBIV in Q2 2022 and held it in 4 quarters. The position peaked at $17K in Q2 2022. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

KeyBank National Association reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
KeyBank National Association sold 713 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $6.48K.
KeyBank National Association first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2022 and held it in 4 quarters.
KeyBank National Association's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $17K in Q2 2022.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on KeyBank National Association's 13F filing for Q2 2023, filed 1 Aug 2023.